Topotecan Terminated Phase 1 Trials for Fallopian Tube Cancer / Cancer of the Ovary / Peritoneal Cavity Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00287859Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer